Subscribe to our newsletter to receive the latest product updates and special offers

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Revenue Breakdown and Options Chain

Gain deeper insights into company revenues with a detailed analysis of revenue sources.
Explore the updated Options feature, providing in-depth data, and a 3D viewing option.

Last Close
Mar 28 04:00PM ET
42.27
Dollar change
-0.11
Percentage change
-0.26
%
IndexRUT P/E- EPS (ttm)-2.67 Insider Own52.09% Shs Outstand181.36M Perf Week0.00%
Market Cap7.68B Forward P/E- EPS next Y-2.49 Insider Trans21.72% Shs Float87.00M Perf Month2.55%
Income-432.84M PEG- EPS next Q-0.71 Inst Own48.47% Short Float8.00% Perf Quarter-0.07%
Sales0.00M P/S- EPS this Y-12.44% Inst Trans4.99% Short Ratio4.40 Perf Half Y100.81%
Book/sh3.71 P/B11.38 EPS next Y4.53% ROA-38.29% Short Interest6.96M Perf Year77.23%
Cash/sh5.46 P/C7.75 EPS next 5Y- ROE-72.44% 52W Range19.59 - 43.59 Perf YTD-0.31%
Dividend Est.- P/FCF- EPS past 5Y- ROI-37.60% 52W High-3.03% Beta1.49
Dividend TTM- Quick Ratio10.92 Sales past 5Y0.00% Gross Margin- 52W Low115.77% ATR (14)0.36
Dividend Ex-Date- Current Ratio10.92 EPS Y/Y TTM-15.07% Oper. Margin0.00% RSI (14)57.78 Volatility0.72% 0.81%
Employees334 Debt/Eq0.71 Sales Y/Y TTM- Profit Margin- Recom3.00 Target Price45.00
Option/ShortYes / Yes LT Debt/Eq0.71 EPS Q/Q-28.02% Payout- Rel Volume0.67 Prev Close42.38
Sales Surprise- EPS Surprise2.74% Sales Q/Q- EarningsNov 01 BMO Avg Volume1.58M Price42.27
SMA201.00% SMA500.83% SMA20032.69% Trades Volume1,058,068 Change-0.26%
Date Action Analyst Rating Change Price Target Change
Dec-08-23Downgrade TD Cowen Outperform → Market Perform $45
Nov-20-23Resumed JP Morgan Neutral $25
Sep-28-23Initiated Piper Sandler Overweight $33
Aug-03-23Downgrade BofA Securities Buy → Neutral $36 → $31
May-04-23Upgrade Wells Fargo Equal Weight → Overweight $30
Apr-10-23Initiated TD Cowen Outperform
Mar-17-23Downgrade JP Morgan Overweight → Neutral $40 → $29
Mar-16-23Resumed Berenberg Hold $22
Feb-23-23Downgrade Wells Fargo Overweight → Equal Weight $38 → $30
Nov-01-22Initiated Loop Capital Buy $40
Mar-17-24 08:50AM
Jan-29-24 02:23PM
Jan-24-24 09:45AM
08:30AM
Jan-23-24 02:45PM
06:10PM Loading…
Jan-02-24 06:10PM
Dec-08-23 07:00AM
Dec-07-23 04:20PM
12:53PM
10:04AM
Dec-06-23 04:46PM
04:30PM
Nov-29-23 06:30AM
Nov-08-23 06:30AM
Nov-01-23 09:14AM
06:30AM Loading…
06:30AM
Oct-13-23 06:30AM
Oct-11-23 10:45PM
04:01PM
Aug-29-23 06:30AM
Aug-11-23 02:21PM
Aug-08-23 06:28AM
Aug-02-23 06:30AM
Jul-05-23 06:30AM
Jun-15-23 06:30AM
May-10-23 06:30AM
May-03-23 06:30AM
Apr-26-23 10:01AM
06:30AM
Apr-11-23 06:30AM
06:30AM Loading…
Mar-21-23 06:30AM
Mar-02-23 06:30AM
Feb-22-23 06:30AM
Feb-01-23 06:30AM
Jan-09-23 06:30AM
Jan-04-23 06:30AM
Dec-31-22 07:55AM
Dec-19-22 06:30AM
Dec-15-22 06:30PM
Nov-11-22 06:30AM
Nov-08-22 06:30AM
Oct-19-22 06:30AM
Sep-06-22 06:30AM
Aug-12-22 06:00AM
06:00AM
Aug-10-22 04:01PM
04:01PM
Aug-01-22 06:15AM
Jul-25-22 05:00PM
Jun-15-22 06:30AM
May-25-22 06:30AM
May-11-22 07:38AM
May-10-22 06:30AM
Apr-28-22 06:00AM
Apr-13-22 06:30AM
Mar-31-22 06:30AM
Mar-21-22 06:30AM
Mar-01-22 06:30AM
Feb-16-22 06:30AM
Feb-15-22 12:50PM
06:30AM
Jan-10-22 06:30AM
Jan-06-22 09:38AM
Jan-03-22 07:00AM
Dec-21-21 05:50AM
Dec-16-21 07:00AM
Nov-10-21 06:30AM
Nov-01-21 06:30AM
Oct-20-21 06:30AM
Oct-07-21 07:00AM
Sep-21-21 05:00PM
Sep-15-21 12:11PM
12:09PM
Sep-10-21 07:00AM
Sep-01-21 07:00AM
Aug-12-21 10:37AM
Aug-11-21 06:30AM
Aug-02-21 01:04PM
Jul-30-21 07:00AM
Jul-22-21 07:00AM
Jul-01-21 09:50PM
Jun-29-21 04:24PM
06:30AM
Jun-24-21 01:44AM
Jun-23-21 07:49PM
Jun-15-21 07:00AM
May-27-21 07:00AM
May-17-21 06:30AM
06:15AM
May-04-21 07:00AM
Apr-29-21 07:00AM
Apr-21-21 07:00AM
Apr-13-21 06:30AM
Mar-24-21 06:30AM
06:15AM
Mar-22-21 07:00AM
Feb-24-21 07:00AM
Jan-29-21 12:14AM
Jan-28-21 07:00AM
Jan-21-21 07:00AM
Cerevel Therapeutics Holdings, Inc. engages in the discovery and development of new therapies for neuroscience diseases. The firm's portfolio focuses on diseases such as schizophrenia, epilepsy, and Parkinson's disease. Its product candidates include CVL-231, Darigabat, Tavapadon, CVL-871, and CVL-936. The company was founded in 2018 and is headquartered in Cambridge, MA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
COLES N ANTHONYDirectorMar 04 '24Option Exercise3.5050,000175,00065,638Mar 06 04:15 PM
COLES N ANTHONYDirectorMar 04 '24Sale41.0150,0002,050,55015,638Mar 06 04:15 PM
COLES N ANTHONYDirectorFeb 29 '24Option Exercise3.5050,000175,00065,638Mar 04 05:49 PM
COLES N ANTHONYDirectorFeb 29 '24Sale41.1650,0002,057,89015,638Mar 04 05:49 PM
COLES N ANTHONYDirectorFeb 07 '24Sale41.542,506104,11015,638Feb 08 07:14 PM
Renger JohnChief Scientific OfficerFeb 07 '24Sale41.542,16189,7776,370Feb 08 07:19 PM
COLES N ANTHONYDirectorJan 02 '24Option Exercise3.5050,000175,00052,704Jan 04 04:15 PM
COLES N ANTHONYDirectorJan 02 '24Sale42.2450,0002,111,8152,704Jan 04 04:15 PM
Sanchez RamiroChief Medical OfficerDec 26 '23Option Exercise3.5010,00035,00024,673Dec 28 04:15 PM
Tregoning KathleenSee RemarksDec 26 '23Option Exercise10.053,15031,65810,666Dec 28 04:15 PM
Sanchez RamiroChief Medical OfficerDec 26 '23Sale42.4710,000424,70014,673Dec 28 04:15 PM
DiPietro KennethChief Human Resources OfficerDec 22 '23Option Exercise3.508,00028,00032,663Dec 27 04:15 PM
DiPietro KennethChief Human Resources OfficerDec 22 '23Sale41.458,000331,60824,663Dec 27 04:15 PM
ALTSCHULLER SusanChief Financial OfficerDec 20 '23Sale41.4213,808571,97216,913Dec 21 08:12 PM
Sanchez RamiroChief Medical OfficerDec 20 '23Sale41.4210,152420,52814,673Dec 21 08:14 PM
Bodenrader MarkSee RemarksDec 20 '23Sale41.427,889326,78817,724Dec 21 08:27 PM
Akamine ScottChief Legal OfficerDec 20 '23Sale41.427,072292,9457,237Dec 21 08:21 PM
Tregoning KathleenSee RemarksDec 20 '23Sale41.426,288260,4697,516Dec 21 08:10 PM
DiPietro KennethChief Human Resources OfficerDec 20 '23Sale41.426,256259,14424,663Dec 21 08:24 PM
Sanchez RamiroChief Medical OfficerDec 15 '23Option Exercise9.887,50074,1007,500Dec 19 04:15 PM
Sanchez RamiroChief Medical OfficerDec 15 '23Sale41.397,500310,3930Dec 19 04:15 PM
Akamine ScottChief Legal OfficerDec 07 '23Option Exercise13.1710,000131,70010,513Dec 07 07:45 PM
Sanchez RamiroChief Medical OfficerDec 07 '23Option Exercise3.5010,00035,00010,000Dec 11 04:17 PM
Sanchez RamiroChief Medical OfficerDec 07 '23Sale41.3710,000413,7000Dec 11 04:17 PM
Akamine ScottChief Legal OfficerDec 07 '23Sale41.3710,000413,700513Dec 07 07:45 PM
Akamine ScottChief Legal OfficerDec 05 '23Option Exercise13.177,50098,7758,013Dec 07 07:45 PM
Akamine ScottChief Legal OfficerDec 05 '23Sale35.007,500262,500513Dec 07 07:45 PM
COLES N ANTHONYDirectorNov 14 '23Option Exercise3.5022,82479,88425,528Nov 16 04:15 PM
COLES N ANTHONYDirectorNov 14 '23Sale25.1322,824573,4552,704Nov 16 04:15 PM
COLES N ANTHONYDirectorNov 08 '23Option Exercise3.501003502,804Nov 09 05:03 PM
COLES N ANTHONYDirectorNov 08 '23Sale25.161002,5162,704Nov 09 05:03 PM
COLES N ANTHONYDirectorNov 07 '23Option Exercise3.5027,07694,76629,780Nov 09 05:03 PM
COLES N ANTHONYDirectorNov 07 '23Sale25.0227,076677,5552,704Nov 09 05:03 PM
COLES N ANTHONYDirectorNov 03 '23Option Exercise3.5061,401214,90464,105Nov 06 05:12 PM
COLES N ANTHONYDirectorNov 03 '23Sale25.4361,4011,561,4582,704Nov 06 05:12 PM
COLES N ANTHONYDirectorNov 02 '23Option Exercise3.5038,599135,09641,303Nov 06 05:12 PM
COLES N ANTHONYDirectorNov 02 '23Sale25.1938,599972,2392,704Nov 06 05:12 PM
PATRICK DEVAL LDirectorNov 01 '23Option Exercise12.6230,130380,24133,412Nov 03 04:15 PM
PATRICK DEVAL LDirectorNov 01 '23Sale25.0030,130753,2503,282Nov 03 04:15 PM
BAIN CAPITAL INVESTORS LLC10% OwnerOct 16 '23Buy22.815,480,052124,999,98665,679,781Oct 18 04:30 PM
Koppel AdamDirectorOct 16 '23Buy22.815,480,052124,999,98665,679,781Oct 18 04:30 PM
Gordon Christopher RDirectorOct 16 '23Buy22.815,480,052124,999,98665,679,781Oct 18 04:30 PM
PERCEPTIVE ADVISORS LLCDirectorOct 16 '23Buy22.81876,80819,999,99010,794,876Oct 17 04:53 PM
COLES N ANTHONYDirectorSep 07 '23Option Exercise3.5050,000175,00052,704Sep 08 04:35 PM
COLES N ANTHONYDirectorSep 07 '23Sale24.0750,0001,203,4152,704Sep 08 04:35 PM
Burgess Paul D.See RemarksAug 04 '23Buy22.9321,880501,79421,880Aug 07 05:11 PM
Renaud Ronald C JRPresident & CEOAug 03 '23Buy23.9683,8572,008,81183,857Aug 07 05:13 PM
COLES N ANTHONYDirectorJul 11 '23Option Exercise3.5050,000175,00052,704Jul 13 05:41 PM
COLES N ANTHONYDirectorJul 11 '23Sale30.0350,0001,501,3402,704Jul 13 05:41 PM
DEKKERS MARIJN EDirectorJun 15 '23Sale34.43200,0006,886,000402,326Jun 20 04:56 PM
Bodenrader MarkSee RemarksJun 02 '23Sale32.951,89562,4405,522Jun 05 08:07 PM
COLES N ANTHONYCEO and ChairpersonJun 01 '23Option Exercise3.5050,000175,00052,704Jun 05 08:12 PM
COLES N ANTHONYCEO and ChairpersonJun 01 '23Sale32.6050,0001,630,0702,704Jun 05 08:12 PM
COLES N ANTHONYCEO and ChairpersonMay 04 '23Option Exercise3.5050,000175,00052,704May 08 04:24 PM
COLES N ANTHONYCEO and ChairpersonMay 04 '23Sale31.4750,0001,573,4342,704May 08 04:24 PM
COLES N ANTHONYCEO and ChairpersonApr 11 '23Option Exercise3.5050,000175,00052,704Apr 13 04:48 PM
COLES N ANTHONYCEO and ChairpersonApr 11 '23Sale25.0650,0001,253,1302,704Apr 13 04:48 PM